drug
(formoterol fumarate + glycopyrrolate)
Marketedupdated 6mo agoby AstraZeneca Pharmaceuticals LP
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
May 28, 2030
~3.6 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (7)
- Mar 17, 2031method-of-use (U-2889)US 88152584.4y
- May 28, 2030formulationUS 107167533.6y
- May 28, 2030method-of-use (U-2889)US 83242663.6y
- May 28, 2030method-of-use (U-2889)US 87038063.6y
- May 28, 2030formulationUS 88087133.6y
- May 28, 2030method-of-use (U-2889)US 94150093.6y
- May 28, 2030formulationUS 94631613.6y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 3h ago
Found something off?
comments(0)
5-min edit window · permanent after that